Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Primary Prevention of Stroke.
Prescription Trends-Brand-name Drugs vs Generic.
Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders.
ACR Appropriateness Criteria® Imaging of Possible Tuberculosis.
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. J Clin Oncol. 2015 Nov 10; 33(32):3817-25.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase II as Topic
Humans
Molecular Targeted Therapy
Neoplasms
Precision Medicine
authors with profiles
Richard Schilsky